相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。mTOR at the nexus of nutrition, growth, ageing and disease
Grace Y. Liu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Chromatin accessibility mapping of the striatum identifies tyrosine kinase FYN as a therapeutic target for heroin use disorder
Gabor Egervari et al.
NATURE COMMUNICATIONS (2020)
Mammalian target of rapamycin complex 1 and its downstream effector collapsin response mediator protein-2 drive reinstatement of alcohol reward seeking
Sami Ben Hamida et al.
ADDICTION BIOLOGY (2019)
A novel rapamycin analog is highly selective for mTORC1 in vivo
Katherine H. Schreiber et al.
NATURE COMMUNICATIONS (2019)
mTORC1 in the orbitofrontal cortex promotes habitual alcohol seeking
Nadege Morisot et al.
ELIFE (2019)
Targeting Fyn Kinase in Alzheimer's Disease
Haakon B. Nygaard
BIOLOGICAL PSYCHIATRY (2018)
Targeting the intracellular signaling STOP and GO pathways for the treatment of alcohol use disorders
Dorit Ron et al.
PSYCHOPHARMACOLOGY (2018)
A new generation of mTORC1 inhibitor attenuates alcohol intake and reward in mice
Nadege Morisot et al.
ADDICTION BIOLOGY (2018)
Region specific activation of the AKT and mTORC1 pathway in response to excessive alcohol intake in rodents
Sophie Laguesse et al.
ADDICTION BIOLOGY (2017)
Prosapip1-Dependent Synaptic Adaptations in the Nucleus Accumbens Drive Alcohol Intake, Seeking, and Reward
Sophie Laguesse et al.
NEURON (2017)
Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013 Results From the National Epidemiologic Survey on Alcohol and Related Conditions
Bridget F. Grant et al.
JAMA PSYCHIATRY (2017)
mTOR Signaling in Growth, Metabolism, and Disease (vol 168, pg 960, 2017)
Robert A. Saxton et al.
CELL (2017)
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma
Qiwen Fan et al.
CANCER CELL (2017)
The BDNF Valine 68 to Methionine Polymorphism Increases Compulsive Alcohol Drinking in Mice That Is Reversed by Tropomyosin Receptor Kinase B Activation
Vincent Warnault et al.
BIOLOGICAL PSYCHIATRY (2016)
The First Alcohol Drink Triggers mTORC1-Dependent Synaptic Plasticity in Nucleus Accumbens Dopamine D1 Receptor Neurons
Jacob T. Beckley et al.
JOURNAL OF NEUROSCIENCE (2016)
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Vanessa S. Rodrik-Outmezguine et al.
NATURE (2016)
Molecular mechanisms underlying alcohol-drinking behaviours
Dorit Ron et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Functional regulation of PI3K-associated signaling in the accumbens by binge alcohol drinking in male but not female mice
Debra K. Cozzoli et al.
NEUROPHARMACOLOGY (2016)
Neurobiologic Advances from the Brain Disease Model of Addiction
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Gene targeting of the transcription factor Mohawk in rats causes heterotopic ossification of Achilles tendon via failed tenogenesis
Hidetsugu Suzuki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond
Dudley W. Lamming
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
mTOR: a pharmacologic target for autophagy regulation
Young Chul Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse
Sebastien Carnicella et al.
ALCOHOL (2014)
Translational Control in Synaptic Plasticity and Cognitive Dysfunction
Shelly A. Buffington et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 37 (2014)
Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition
Atsushi Umemura et al.
CELL METABOLISM (2014)
mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse
Jeremie Neasta et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Systemic inhibition of mTOR kinase via rapamycin disrupts consolidation and reconsolidation of auditory fear memory
Phillip E. Mac Callum et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2014)
A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response
Ning Ding et al.
CELL (2013)
Duration of Rapamycin Treatment Has Differential Effects on Metabolism in Mice
Yimin Fang et al.
CELL METABOLISM (2013)
mTOR is a key modulator of ageing and age-related disease
Simon C. Johnson et al.
NATURE (2013)
Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse
Segev Barak et al.
NATURE NEUROSCIENCE (2013)
mTOR complexes in neurodevelopmental and neuropsychiatric disorders
Mauro Costa-Mattioli et al.
NATURE NEUROSCIENCE (2013)
Object recognition test in mice
Marianne Leger et al.
NATURE PROTOCOLS (2013)
Chromatin remodeling - a novel strategy to control excessive alcohol drinking
V. Warnault et al.
TRANSLATIONAL PSYCHIATRY (2013)
Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation: A Critical Review of the Literature
Bjoern Nashan et al.
TRANSPLANTATION (2012)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Fighting neurodegeneration with rapamycin: mechanistic insights
Jordi Bove et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Dissecting the role of mTOR: Lessons from mTOR inhibitors
Ryan J. O. Dowling et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue
Vanessa P. Houde et al.
DIABETES (2010)
Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders
Jeremie Neasta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation
Jacqueline Blundell et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)